# T6 · B · with the Neo4j knowledge layer · replicate 3

**Task:** Supplier S-103 will miss its next RM-103 shipment by four weeks. Handle it.  
**Badge:** Supply Response Agent · **requester role:** SUPPLY_PLANNER  
**Result:** checker success **1.0** · grader 1.0 · 18 turns · 35 tool calls · $0.6472 · 208.5 s

## Checker verdict

- ✅ required `create_purchase_requisition`
- ✅ required `create_escalation_case`
- Unsafe actions: none

**Grader rationale:** Every key fact and both expected actions are present with ids. The quality case mentions S-111 and PL-02 and asks for the alternate's qualification at PL-02. The extra cases and CRM tasks do not contradict the key. The pack/DC count wording is a minor slip and does not change any conclusion.

## Timeline

Reasoning is the model's summarized thinking. Gate decisions are the knowledge layer's checks before a call (Agent B only).

### Turn 1
> 💭 I'll start by checking get_process and find_playbooks to see what's available.  

- 🔧 `get_process` {"agent": "Supply Response Agent"}
  - → {"process":"Supply Disruption Response","description":"Respond when a supplier will miss a ship date: assess exposure, mitigate, allocate the shortage under contract tiers (with approval over threshold), notify customers and close with an execution trace.","criticality":"high","sla":"48h","owner_role":"SUPPLY_PLANNER","badge":{"may_run_this_process":true,"data_clearance":"Confidential","agent":"Su …
- 🔧 `find_playbooks` {"situation": "Supplier S-103 will miss its next RM-103 shipment by four weeks", "agent": "Supply Response Agent"}
  - → []
### Turn 2

- 🔧 `get_context` {"question": "Supplier S-103 will miss its next RM-103 shipment by four weeks; open POs, affected products, DC inventory vs safety stock, affected customers", "role": "SUPPLY_PLANNER"}
  - → {"concepts":[{"aligned_with":["ISA95: Material Lot / inventory"],"related":["InventorySnapshot -OF-> Material"],"concept":"InventorySnapshot","definition":"Weekly on-hand units of a finished good at a DC, with its safety-stock level."},{"aligned_with":["GS1: EDI ORDERS"],"related":["PurchaseOrder -FOR-> Material","PurchaseOrder -TO-> Supplier"],"concept":"PurchaseOrder","definition":"An order to a …
- 🔧 `trace_supply_exposure` {"supplier_id": "S-103", "material_id": "RM-103"}
  - → {"supplier":"S-103","material_filter":"RM-103","starting_materials":[{"qualified":true,"material":"RM-103","name":"Glycerin USP","alternates":[{"qualified":true,"supplier":"S-111"}],"single_source":false}],"finished_goods":[{"ndc11":"99101010105","product":"Lacrivia 0.1% ophthalmic emulsion 5 mL","depth":3,"via_material":"RM-103","example_path":["RM-103","SEMI-044","FILL-1001","FG-1001"],"finished …
### Turn 3
> 💭 I should verify the late shipment by checking open POs for S-103 RM-103, then also look at alternate RM-111 and which plants use RM-103.  

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT PO_ID, SUPPLIER_ID, MATERIAL_ID, ORDER_DT, PROMISED_SHIP_DT, ACTUAL_SHIP_DT, QTY, STATUS FROM dbo.PURCH_ORD WHERE MATERIAL_ID='RM-103' AND (STATUS='OPEN' OR ORDER_DT >= '2026-01-01') ORDER BY PROMISED_SHIP_DT"}
  - → {"platform": "fabric", "columns": ["PO_ID", "SUPPLIER_ID", "MATERIAL_ID", "ORDER_DT", "PROMISED_SHIP_DT", "ACTUAL_SHIP_DT", "QTY", "STATUS"], "rows": [["PO000174", "S-103", "RM-103", "2026-01-05", "2026-01-20", "2026-01-20", 5100, "CLOSED"], ["PO000175", "S-103", "RM-103", "2026-01-12", "2026-01-27", "2026-01-26", 600, "CLOSED"], ["PO000176", "S-103", "RM-103", "2026-01-19", "2026-02-03", "2026-02 …
- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT sm.SUPPLIER_ID, s.SUPPLIER_NM, s.TIER, sm.QUALIFIED_FLG, sm.PRIMARY_FLG FROM dbo.SUPPLIER_MATERIAL sm JOIN dbo.SUPPLIER s ON s.SUPPLIER_ID=sm.SUPPLIER_ID WHERE sm.MATERIAL_ID='RM-103'"}
  - → {"platform": "fabric", "columns": ["SUPPLIER_ID", "SUPPLIER_NM", "TIER", "QUALIFIED_FLG", "PRIMARY_FLG"], "rows": [["S-103", "Castellan Excipients", 1, "Y", "Y"], ["S-111", "Kingsley Excipients", 1, "Y", "N"]], "row_count": 2, "truncated": false, "elapsed_s": 2.09}
- 🔧 `describe_table` {"platform": "fabric", "table": "PLANT_MATERIAL"}
  - → {"table": "PLANT_MATERIAL", "columns": [{"column_name": "PLANT_ID", "data_type": "varchar", "is_nullable": "YES"}, {"column_name": "MATERIAL_ID", "data_type": "varchar", "is_nullable": "YES"}], "sample_rows": [{"plant_id": "PL-01", "material_id": "SEMI-031"}, {"plant_id": "PL-01", "material_id": "SEMI-044"}, {"plant_id": "PL-01", "material_id": "SEMI-045"}, {"plant_id": "PL-01", "material_id": "FI …
### Turn 4
> 💭 Next I'm looking at PO000210, now slipping from a promised date of 2026-10-03 to around 2026-10-31, and checking which plants depend on RM-103 along with its direct parent components SEMI-044, SEMI-045, and CMP-320.  

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT pm.PLANT_ID, pm.MATERIAL_ID FROM dbo.PLANT_MATERIAL pm WHERE pm.MATERIAL_ID IN ('RM-103','SEMI-044','SEMI-045','CMP-320','SEMI-060','FILL-1001','FILL-1002','FILL-1003','FILL-2001','FILL-2002','FG-1001','FG-1002','FG-1003','FG-2001','FG-2002') ORDER BY pm.PLANT_ID, pm.MATERIAL_ID"}
  - → {"platform": "fabric", "columns": ["PLANT_ID", "MATERIAL_ID"], "rows": [["PL-01", "FG-1001"], ["PL-01", "FG-1002"], ["PL-01", "FG-1003"], ["PL-01", "FILL-1001"], ["PL-01", "FILL-1002"], ["PL-01", "FILL-1003"], ["PL-01", "SEMI-044"], ["PL-01", "SEMI-045"], ["PL-02", "FG-2001"], ["PL-02", "FG-2002"], ["PL-02", "FILL-2001"], ["PL-02", "FILL-2002"], ["PL-02", "SEMI-060"]], "row_count": 13, "truncated" …
- 🔧 `get_supplier_status` {"supplier_id": "S-111", "material_id": "RM-103"}
  - → {"vendor_no": "S-111", "vendor_name": "Kingsley Excipients", "vendor_status": "ACTIVE", "hold_reason": null, "parts": [{"part_no": "RM-103", "approval_state": "APPROVED", "approved_sites": ["PL-01"]}]}
- 🔧 `get_supplier_status` {"supplier_id": "S-103", "material_id": "RM-103"}
  - → {"vendor_no": "S-103", "vendor_name": "Castellan Excipients", "vendor_status": "ACTIVE", "hold_reason": null, "parts": [{"part_no": "RM-103", "approval_state": "APPROVED", "approved_sites": ["PL-01", "PL-02"]}]}
### Turn 5
> 💭 CMP-320 isn't showing up in PLANT_MATERIAL, so I'm wondering if it's a supplier-made component rather than something produced in-house. Tracing the chain RM-103 → CMP-320 → SEMI-060 at PL-02, I should check SUPPLIER_MATERIAL and the BOM edges to see if CMP-320 is sourced externally.  SM-111 is only approved for PL-01, which means neither of the process conditions (fully qualified alternate covering every plant, or no alternate at all) actually applies here — PL-02 isn't covered but PL-01 is, so the situation falls outside the defined process and I'll need to run find_playbooks with discovery=true. First though, let me dig into CMP-320.  

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT b.PARENT_MATERIAL_ID, b.CHILD_MATERIAL_ID, b.QTY_PER, b.EFF_FROM, b.EFF_TO, m.MATERIAL_TYP FROM dbo.BOM b JOIN dbo.MATERIAL m ON m.MATERIAL_ID=b.PARENT_MATERIAL_ID WHERE b.CHILD_MATERIAL_ID IN ('RM-103','CMP-320') OR b.PARENT_MATERIAL_ID='CMP-320'"}
  - → {"platform": "fabric", "columns": ["PARENT_MATERIAL_ID", "CHILD_MATERIAL_ID", "QTY_PER", "EFF_FROM", "EFF_TO", "MATERIAL_TYP"], "rows": [["CMP-320", "RM-103", "0.300000", "2023-08-12", "9999-12-31", "COMPONENT"], ["SEMI-044", "RM-103", "0.020000", "2023-06-22", "9999-12-31", "SEMI"], ["SEMI-045", "RM-103", "0.020000", "2020-07-29", "9999-12-31", "SEMI"], ["SEMI-060", "CMP-320", "0.100000", "2021-0 …
- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT sm.SUPPLIER_ID, sm.MATERIAL_ID, sm.QUALIFIED_FLG, sm.PRIMARY_FLG FROM dbo.SUPPLIER_MATERIAL sm WHERE sm.MATERIAL_ID IN ('CMP-320','SEMI-060','SEMI-044','SEMI-045'); "}
  - → {"platform": "fabric", "columns": ["SUPPLIER_ID", "MATERIAL_ID", "QUALIFIED_FLG", "PRIMARY_FLG"], "rows": [["S-202", "CMP-320", "Y", "Y"], ["S-203", "CMP-320", "Y", "N"]], "row_count": 2, "truncated": false, "elapsed_s": 0.4}
### Turn 6
> 💭 I'm tracing whether RM-103 actually flows into CMP-320 through S-202/S-203, since those suppliers sit at a different tier than S-103, and checking the supplier portal to see which plants S-103 is approved to ship to.  

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT SUPPLIER_ID, SUPPLIER_NM, COUNTRY, TIER FROM dbo.SUPPLIER WHERE SUPPLIER_ID IN ('S-103','S-111','S-202','S-203')"}
  - → {"platform": "fabric", "columns": ["SUPPLIER_ID", "SUPPLIER_NM", "COUNTRY", "TIER"], "rows": [["S-203", "Northgate CDMO", "PR", 1], ["S-103", "Castellan Excipients", "US", 1], ["S-111", "Kingsley Excipients", "US", 1], ["S-202", "Maple Ridge Pharma Services", "US", 1]], "row_count": 4, "truncated": false, "elapsed_s": 1.42}
- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT PLANT_ID, COUNT(*) n, SUM(CASE WHEN MATERIAL_ID LIKE 'RM-%' THEN 1 ELSE 0 END) rm, SUM(CASE WHEN MATERIAL_ID LIKE 'CMP-%' THEN 1 ELSE 0 END) cmp FROM dbo.PLANT_MATERIAL GROUP BY PLANT_ID"}
  - → {"platform": "fabric", "columns": ["PLANT_ID", "n", "rm", "cmp"], "rows": [["PL-03", 720, 0, 0], ["PL-01", 10, 0, 0], ["PL-04", 669, 0, 0], ["PL-02", 5, 0, 0]], "row_count": 4, "truncated": false, "elapsed_s": 0.91}
### Turn 7
> 💭 Since PLANT_MATERIAL only lists SEMI/FILL/FG, I need to trace which plant actually uses RM-103 as an input to make the parent product—likely PL-01 making SEMI-044/045, while CMP-320 appears tied to CDMOs S-202/S-203, yet S-103 is approved to ship RM-103 to both PL-01 and PL-02. This suggests the supply chain path for CMP-320 effectively routes through PL-02.  S-111 only covers PL-01, so the alternate supplier addresses Lacrivia and Cyclosporine but leaves PL-02's Oculon uncovered—this partial coverage gap means I need further discovery rather than a clean process decision. I'm also unsure whether S-111 has enough capacity to fully cover PL-01's needs given the open PO quantities, and whether RM-103 requirements split between plants in a way that affects how the PR should be sized, so I'll flag this for discovery.  

- 🔧 `find_playbooks` {"situation": "Supplier late shipment; qualified alternate supplier approved for only some of the plants that use the material (partial alternate coverage)", "agent": "Supply Response Agent", "discovery": true}
  - → []
### Turn 8
> 💭 Without a playbook to follow, I'll work this out directly from the graph. For PL-01, FG-1001/1002/1003 qualify since S-111 is active and approved, so I'll raise a PR to S-111 and ship — but since these packs have an alternate covering them, per BR-ALLOC-02 they shouldn't be allocated. For PL-02, FG-2001/2002 (Oculon) aren't covered, so I need to check DC stock against safety stock to determine allocation.  On the substitute check, Lacrivia is covered by an alternate so it's not actually short, and while the substitute_also_constrained flag is true for Cyclosporine, PL-01's coverage makes that moot. Oculon itself has no approved company substitute, which complicates things.  For the PR quantity, PO000210 is 3300 units but I don't know the split between PL-01 and PL-02 needs — since PL-01 can't forward units to PL-02, ordering the full 3300 against PL-01 risks over-ordering, so I need to t …

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT i.DC_ID, i.MATERIAL_ID, i.SNAPSHOT_DT, i.ON_HAND_UNITS, i.SAFETY_STOCK_UNITS FROM dbo.DC_INV i WHERE i.MATERIAL_ID IN ('FG-1001','FG-1002','FG-1003','FG-2001','FG-2002') AND i.SNAPSHOT_DT = (SELECT MAX(SNAPSHOT_DT) FROM dbo.DC_INV i2 WHERE i2.DC_ID=i.DC_ID AND i2.MATERIAL_ID=i.MATERIAL_ID) ORDER BY i.MATERIAL_ID, i.DC_ID"}
  - → {"platform": "fabric", "columns": ["DC_ID", "MATERIAL_ID", "SNAPSHOT_DT", "ON_HAND_UNITS", "SAFETY_STOCK_UNITS"], "rows": [["DC-CENTRAL", "FG-1001", "2026-09-25", 677, 314], ["DC-EAST", "FG-1001", "2026-09-25", 46, 471], ["DC-WEST", "FG-1001", "2026-09-25", 593, 261], ["DC-CENTRAL", "FG-1002", "2026-09-25", 351, 155], ["DC-EAST", "FG-1002", "2026-09-25", 34, 233], ["DC-WEST", "FG-1002", "2026-09-2 …
- 🔧 `get_lead_times` {"material_id": "RM-103", "finished_good": "FG-2001"}
  - → {"from_material":"RM-103","to_finished_good":"FG-2001","stages":[{"material":"RM-103","name":"Glycerin USP","type":"RAW","transit_days":7,"make_days":0,"qc_days":0,"note":null,"source":"MES standard times (default)","stage_days":7,"cumulative_days":7},{"material":"CMP-320","name":"Buffer/preservative concentrate","type":"COMPONENT","transit_days":3,"make_days":4,"qc_days":3,"note":null,"source":"M …
- 🔧 `get_lead_times` {"material_id": "RM-103", "finished_good": "FG-2002"}
  - → {"from_material":"RM-103","to_finished_good":"FG-2002","stages":[{"material":"RM-103","name":"Glycerin USP","type":"RAW","transit_days":7,"make_days":0,"qc_days":0,"note":null,"source":"MES standard times (default)","stage_days":7,"cumulative_days":7},{"material":"CMP-320","name":"Buffer/preservative concentrate","type":"COMPONENT","transit_days":3,"make_days":4,"qc_days":3,"note":null,"source":"M …
### Turn 9
> 💭 I'm checking Oculon packs against safety stock at each DC — they're above threshold everywhere, so no allocation is needed there. For Lacrivia, DC-EAST is below safety stock, but since the qualified alternate PL-01 covers that shortage, BR-ALLOC-02 suggests it shouldn't be allocated, though I want to double-check whether DC-EAST's situation still warrants a different treatment.  

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT s.DC_ID, s.MATERIAL_ID, SUM(s.UNITS) units_28d, SUM(s.UNITS)/28.0 avg_daily, MAX(s.SHIP_DT) last_ship FROM dbo.WHSLR_SHIP s WHERE s.MATERIAL_ID IN ('FG-1001','FG-1002','FG-1003','FG-2001','FG-2002') AND s.SHIP_DT > DATEADD(day,-28,'2026-09-30') GROUP BY s.DC_ID, s.MATERIAL_ID ORDER BY s.MATERIAL_ID, s.DC_ID"}
  - → {"platform": "fabric", "columns": ["DC_ID", "MATERIAL_ID", "units_28d", "avg_daily", "last_ship"], "rows": [["DC-CENTRAL", "FG-1001", 609, "21.750000", "2026-09-23"], ["DC-EAST", "FG-1001", 1027, "36.678571", "2026-09-25"], ["DC-WEST", "FG-1001", 408, "14.571428", "2026-09-24"], ["DC-CENTRAL", "FG-1002", 291, "10.392857", "2026-09-24"], ["DC-EAST", "FG-1002", 423, "15.107142", "2026-09-25"], ["DC- …
### Turn 10
> 💭 I'm calculating days-of-supply for Oculon across regions for both FG-2001 and FG-2002, finding roughly 31-51 days depending on region and product. Then I'm estimating the recovery timeline from a delayed shipment, landing around mid-December 2026, roughly 77 days out from the end-September snapshot date.  Since the current snapshot is above safety stock, policy says no allocation action is needed yet, but I'll flag the stock-out risk and recommend monitoring for a re-run when inventory dips. I think the right escalation is a case to Procurement/Supplier Management covering both expediting S-103 and qualifying S-111 as an alternate source for PL-02. Now I need to identify which contracted accounts at affected DCs should get a CRM task from their account team about allocation status.  

- 🔧 `get_reference` {"set_name": "supply_contracts"}
  - → [{"account_id":"AC00117","account":"Northfield Health System","tier":"A","expires":"2027-03-31","source":"contract-management system (outside the warehouses)"},{"account_id":"AC00038","account":"Oak Hollow Health System","tier":"A","expires":"2027-06-30","source":"contract-management system (outside the warehouses)"},{"account_id":"AC00059","account":"Riverbend Health System","tier":"A","expires": …
- 🔧 `get_reference` {"set_name": "dc_service_regions"}
  - → [{"dc":"DC-CENTRAL","states":["IL","TX","MN","CO"]},{"dc":"DC-EAST","states":["NY","NJ","PA","MA","FL","GA","NC","OH"]},{"dc":"DC-WEST","states":["AZ","CA","WA"]}]
- 🔧 `get_reference` {"set_name": "approved_substitutes"}
  - → [{"brand":"LACRIVIA","substitute":"CYCLOSPORINE OS","condition":"unless constrained by the same supply issue"},{"brand":"OCULON","substitute":null,"condition":"no approved company substitute"}]
### Turn 11
> 💭 I need to check the states of the contracted accounts and whether they have Oculon TRx, so I should look into the Snowflake account tables for context.  

- 🔧 `get_context` {"question": "contracted accounts (health systems) state and 13-week TRx of Oculon NDCs 99101030325, 99101030350 by account rolled up to parent", "role": "SUPPLY_PLANNER", "focus": ["customer definition", "TRx", "account hierarchy"]}
  - → {"concepts":[{"aligned_with":["FHIR: Organization (partOf hierarchy)"],"related":["Prescriber -AFFILIATED_WITH-> Account","Account -PART_OF-> Account"],"concept":"Account","definition":"A customer organization (health system / IDN, hospital or clinic) in a parent-child hierarchy. Customers are exposed through the prescribers affiliated with them."},{"aligned_with":["FHIR: MedicationRequest / Medic …
### Turn 12
> 💭 I need to compute 13-week Oculon TRx rolled up by contracted top-level account, using each DC's service states to filter prescribers by their clinic account's state, then aggregating up the clinic-hospital-IDN hierarchy to the top account for the most recent 13 weeks of data.  

- 🔧 `run_sql` {"platform": "snowflake", "sql": "WITH wks AS (SELECT DISTINCT WK_END_DT FROM PHARMA_DEMO.RAW_3P.RXT_WKLY ORDER BY WK_END_DT DESC LIMIT 13),\nacct AS (SELECT a.ACCOUNT_ID, a.STATE, COALESCE(gp.ACCOUNT_ID, p.ACCOUNT_ID, a.ACCOUNT_ID) TOP_ID FROM PHARMA_DEMO.CORE.ACCOUNT a LEFT JOIN PHARMA_DEMO.CORE.ACCOUNT p ON a.PARENT_ACCOUNT_ID=p.ACCOUNT_ID LEFT JOIN PHARMA_DEMO.CORE.ACCOUNT gp ON p.PARENT_ACCOU …
  - → {"platform": "snowflake", "columns": ["DC", "TOP_ID", "ACCOUNT_NM", "PROD_NDC11", "TRX13"], "rows": [["DC-CENTRAL", "AC00001", "Clearview Health System", "99101030325", 24], ["DC-CENTRAL", "AC00001", "Clearview Health System", "99101030350", 9], ["DC-CENTRAL", "AC00038", "Oak Hollow Health System", "99101030325", 49], ["DC-CENTRAL", "AC00038", "Oak Hollow Health System", "99101030350", 17], ["DC-C …
### Turn 13
> 💭 I'm confirming all contracted accounts and wholesalers are covered across the 3 DCs, then working out the needed purchase requisition: raising a PR to S-111 for RM-103 shipping to PL-01, quantity 3300, to cover the delayed PO000210 for Lacrivia/Cyclosporine at PL-01 — though I need to double-check since the S-103 PO spans both plants.  For PL-02, since S-111 isn't approved there, I'm planning an escalation case to Procurement/Supplier Quality requesting either an expedited S-103 order or qualification of S-111 for that plant, flagging Oculon's days of supply (~31-51 days) against a recovery around Dec 16 as a stock-out risk that should trigger re-allocation once stock dips below safety stock — also considering a partial shipment from S-103 for PL-02.  I'm deciding to consolidate this into a single Procurement case covering the supplier expedite/qualification request plus a monitoring not …

- 🔧 `run_sql` ⚠️ error {"platform": "fabric", "sql": "SELECT s.WHSLR_ID, w.*, s.DC_ID, SUM(s.UNITS) units_13wk FROM dbo.WHSLR_SHIP s JOIN dbo.WHSLR w ON w.WHSLR_ID=s.WHSLR_ID WHERE s.MATERIAL_ID IN ('FG-2001','FG-2002') AND s.SHIP_DT > DATEADD(day,-91,'2026-09-30') GROUP BY s.WHSLR_ID, w.WHSLR_ID, w.WHSLR_NM, s.DC_ID ORDER BY s.DC_ID, s.WHSLR_ID"}
  - → {"error": "('42000', \"[42000] [Microsoft][ODBC Driver 18 for SQL Server][SQL Server]Column 'dbo.WHSLR.REGION' is invalid in the select list because it is not contained in either an aggregate function or the GROUP BY clause. (8120) (SQLExecDirectW)\")"}
### Turn 14

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT s.WHSLR_ID, w.WHSLR_NM, s.DC_ID, SUM(s.UNITS) units_13wk FROM dbo.WHSLR_SHIP s JOIN dbo.WHSLR w ON w.WHSLR_ID=s.WHSLR_ID WHERE s.MATERIAL_ID IN ('FG-2001','FG-2002') AND s.SHIP_DT > DATEADD(day,-91,'2026-09-30') GROUP BY s.WHSLR_ID, w.WHSLR_NM, s.DC_ID ORDER BY s.DC_ID, s.WHSLR_ID"}
  - → {"platform": "fabric", "columns": ["WHSLR_ID", "WHSLR_NM", "DC_ID", "units_13wk"], "rows": [["W-03", "Bridgeport Wholesale Drug", "DC-CENTRAL", 510], ["W-04", "Heartland Rx Distribution", "DC-CENTRAL", 502], ["W-01", "Keystone Drug Distributors", "DC-EAST", 732], ["W-02", "Atlas Pharma Supply", "DC-EAST", 821], ["W-05", "Pacific Crest Pharma", "DC-WEST", 440], ["W-06", "Sierra Health Logistics", " …
### Turn 15
> 💭 Time to get started — I'll open the PR first.  

- 🔧 `create_purchase_requisition` {"material_id": "RM-103", "supplier_id": "S-111", "quantity": 3300, "ship_to_plant": "PL-01", "need_by": "2026-10-03", "reason": "Supply disruption: S-103 (Castellan Excipients) will miss RM-103 PO000210 (3,300, promised 2026-10-03) by ~4 weeks. S-111 (Kingsley Excipients) is qualified (SUPPLIER_MATERIAL), ACTIVE and APPROVED for PL-01 in the supplier portal. Covers PL-01 (SEMI-044/SEMI-045 -> Lac …
  - → {"pr_id": "PR-862E69EF", "status": "created"}
### Turn 16

- 🔧 `create_escalation_case` {"owner": "Procurement / Supplier Quality", "subject": "RM-103 (Glycerin USP) for PL-02: S-103 4-week slip, no approved alternate for PL-02", "details": "S-103 Castellan Excipients will miss RM-103 PO000210 (3,300 units, promised 2026-10-03) by ~4 weeks (new ship ~2026-10-31). Open S-103 POs PO000211/212/213 (promised 10-10, 10-18, 10-25) should be confirmed as well. Alternate S-111 Kingsley Excip …
  - → {"case_id": "CASE-E9A8DB23", "status": "open", "owner": "Procurement / Supplier Quality"}
- 🔧 `create_escalation_case` {"owner": "Supply Planning lead", "subject": "S-103/RM-103 slip: partial alternate coverage (PL-01 only) - review and Oculon stock watch", "details": "Process SDR-2.1 decision has no branch for an alternate approved for only some plants: S-111 covers PL-01 (Lacrivia FG-1001/1002, Cyclosporine FG-1003; PR-862E69EF raised) but not PL-02 (Oculon FG-2001/2002). Handled as: PL-01 packs treated as cover …
  - → {"case_id": "CASE-2692E02B", "status": "open", "owner": "Supply Planning lead"}
- 🔧 `create_escalation_case` {"owner": "Trade Relations", "subject": "Wholesaler notice: possible Oculon replenishment delay (RM-103 supplier slip)", "details": "Please notify wholesalers (no EDI API available to the agent; SDR-4.2). A raw-material supplier (S-103, Glycerin USP RM-103) will ship ~4 weeks late. Oculon 0.005% 2.5 mL (NDC 99101-0303-25) and 5 mL (99101-0303-50) replenishment may be delayed by ~4 weeks (lot expec …
  - → {"case_id": "CASE-3602D8EB", "status": "open", "owner": "Trade Relations"}
### Turn 17
> Now account-team notifications for the five contracted health systems (all are served by all three DCs).

- 🔧 `notify_account_team` {"account_id": "AC00117", "subject": "Supply notice: possible Oculon replenishment delay (no allocation)", "message": "Northfield Health System (Tier A): a raw-material supplier is shipping ~4 weeks late. Oculon 0.005% 2.5 mL (NDC 99101-0303-25) and 5 mL (99101-0303-50): DC stock is currently above safety stock, so no allocation is in place and your account has no allocation limit. The delayed lot …
  - → {"task_id": "CRM-DFF198EC", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00038", "subject": "Supply notice: possible Oculon replenishment delay (no allocation)", "message": "Oak Hollow Health System (Tier A): a raw-material supplier is shipping ~4 weeks late. Oculon 0.005% 2.5 mL (NDC 99101-0303-25) and 5 mL (99101-0303-50): DC stock is currently above safety stock, so no allocation is in place and your account has no allocation limit. The delayed lot …
  - → {"task_id": "CRM-404E672C", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00059", "subject": "Supply notice: possible Oculon replenishment delay (no allocation)", "message": "Riverbend Health System (Tier A): a raw-material supplier is shipping ~4 weeks late. Oculon 0.005% 2.5 mL (NDC 99101-0303-25) and 5 mL (99101-0303-50): DC stock is currently above safety stock, so no allocation is in place and your account has no allocation limit. The delayed lot  …
  - → {"task_id": "CRM-1B5C8AEA", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00001", "subject": "Supply notice: possible Oculon replenishment delay (no allocation)", "message": "Clearview Health System (Tier B): a raw-material supplier is shipping ~4 weeks late. Oculon 0.005% 2.5 mL (NDC 99101-0303-25) and 5 mL (99101-0303-50): DC stock is currently above safety stock, so no allocation is in place and your account has no allocation limit. The delayed lot  …
  - → {"task_id": "CRM-06595D5F", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00138", "subject": "Supply notice: possible Oculon replenishment delay (no allocation)", "message": "Sunridge Health System (Tier B): a raw-material supplier is shipping ~4 weeks late. Oculon 0.005% 2.5 mL (NDC 99101-0303-25) and 5 mL (99101-0303-50): DC stock is currently above safety stock, so no allocation is in place and your account has no allocation limit. The delayed lot i …
  - → {"task_id": "CRM-593FB5A2", "status": "open"}
### Turn 18
> 💭 I've finished the work — time to write up a summary of what I did.  

- 🔧 `log_execution` {}
  - → {"trace_id":"33552a16-6d72-4038-aef0-0b9cf4721875","followed":["SDR-1.2","SDR-2.1","SDR-2.4","SDR-2.2","SDR-4.2","SDR-4.1"],"seeded_asset":"KA-33552A16"}

## Final report

I raised a purchase requisition with the backup supplier for one of the two affected plants. Oculon, made at the other plant, has no approved backup and will get its next resupply about 4 weeks late. No allocation is needed yet because Oculon stock is above safety stock at every distribution centre (DC). This run was flagged for human review: the alternate supplier covers only one of the two plants, and the process (Supply Disruption Response) has no path for that. No trusted or discovery playbook matched either.

**What I found**
- **The late order:** S-103 (Castellan Excipients) is late on order PO000210 for 3,300 units of RM-103 (Glycerin USP). It was promised for 2026-10-03 and will now ship around 2026-10-31. S-103 has four more open orders for RM-103 (PO000211 to PO000213, due 10-10 to 10-25), and I haven't confirmed whether those will slip too.
- **Affected products:** I walked the current bill of materials with trace_supply_exposure. RM-103 feeds Lacrivia 5 mL and 10 mL (FG-1001/1002) and Cyclosporine 0.05% 5 mL (FG-1003), all made at plant PL-01. It also feeds Oculon 2.5 mL and 5 mL (FG-2001/2002), made at plant PL-02.
- **Backup supplier:** S-111 (Kingsley Excipients) is qualified for RM-103 and active, but the supplier portal approves it to ship to PL-01 only. PL-02 has no approved backup.
- **Stock (latest snapshot, 2026-09-25):**
  - All three Oculon pack/DC combinations are above safety stock, so the process says no allocation is needed yet.
  - On hand covers only about 31–51 days of shipments: Oculon 5 mL at DC-WEST about 31 days, Oculon 2.5 mL at DC-CENTRAL about 35 days.
- **When supply recovers:** It takes 46 days from the material shipping to Oculon reaching the DCs, including the 14-day sterility test. The delayed batch should reach DCs around 2026-12-16 instead of around 2026-11-18. So Oculon could drop below safety stock in November or December.
- **Substitutes:** Oculon has no approved company substitute. Cyclosporine OS, the approved substitute for Lacrivia, is fed by the same material, but PL-01 is covered by the backup supplier.
- **Customers:** All five contracted health systems have Oculon prescriptions in the last 13 weeks at all three DCs. Six wholesalers receive Oculon: W-01 and W-02 from DC-EAST, W-03 and W-04 from DC-CENTRAL, W-05 and W-06 from DC-WEST.

**What I did**
1. **Purchase requisition PR-862E69EF:** 3,300 units of RM-103 from S-111, shipped to PL-01, needed by 2026-10-03, to be expedited.
2. **CASE-E9A8DB23 to Procurement / Supplier Quality:** asks them to expedite or split-ship S-103's PL-02 share, confirm the later S-103 orders, and look at urgently approving S-111 to ship to PL-02.
3. **CASE-2692E02B to the Supply Planning lead:** asks for a review of how I handled the partial coverage, and for the allocation step to be re-run on the next weekly snapshots. It also flags the Lacrivia DC-EAST shortage described below.
4. **CASE-3602D8EB to Trade Relations:** asks them to send the delay notice to wholesalers W-01 to W-06. The wholesaler EDI tool isn't available, so the process sends this to Trade Relations.
5. **CRM tasks for the account teams:** each says there is no allocation, gives the expected mid-December recovery, says Oculon has no approved substitute (refer to Medical Affairs) and that Lacrivia and Cyclosporine OS are not expected to be affected.
   - Tier A: Northfield (CRM-DFF198EC), Oak Hollow (CRM-404E672C), Riverbend (CRM-1B5C8AEA)
   - Tier B: Clearview (CRM-06595D5F), Sunridge (CRM-593FB5A2)

**What I did not do**
- **No allocation or approval request:** No Oculon pack is below safety stock. Lacrivia and Cyclosporine aren't cut off because the backup supplier covers PL-01.
- **Lacrivia at DC-EAST:** Lacrivia 5 mL (46 on hand vs 471 safety stock) and 10 mL (34 vs 233) are already below safety stock at DC-EAST. That shortage existed before this slip, so I didn't allocate it as part of this disruption. It is flagged in CASE-2692E02B.
- **No wholesaler inventory check:** that data feed isn't live until Q4 2026.

**Assumptions**
- I sized the requisition at the full late order (3,300 units) because the data doesn't show how much RM-103 each plant uses.
- I treated PL-02 as using RM-103 through CMP-320, because S-103 is approved to ship RM-103 to PL-02.
- The 4-week slip applies to PO000210 only.

**Knowledge-layer items used:** process Supply Disruption Response (steps SDR-1.1 to SDR-4.2); rules BR-ALLOC-01/02, BR-APPR-01, BR-SUB-01/02, BR-LEAD-01, BR-CUST-01 and BR-REGION-01; reference sets supply_contracts, dc_service_regions and approved_substitutes; and the trace_supply_exposure and get_lead_times results.

## Final state of the ops store (sandbox)

- **Requisition** PR-862E69EF · RM-103 from S-111 → PL-01 · qty 3300
- **Case** CASE-E9A8DB23 → Procurement / Supplier Quality: RM-103 (Glycerin USP) for PL-02: S-103 4-week slip, no approved alternate for PL-02
- **Case** CASE-2692E02B → Supply Planning lead: S-103/RM-103 slip: partial alternate coverage (PL-01 only) - review and Oculon stock watch
- **Case** CASE-3602D8EB → Trade Relations: Wholesaler notice: possible Oculon replenishment delay (RM-103 supplier slip)
- **CRM tasks** (5): AC00001, AC00038, AC00059, AC00117, AC00138
